BIVI vs KSCP Comparison

BioVie Inc is a clinical-stage company developing drug therapies for the treatment of neurological and neurodegenerative disorders and liver disease. Its therapeutic areas include Alzheimer's, Parkinson's, Long COVID, Ascites, Longevity, and Epigenetics. In liver disease, its investigational drug candidate BIV201 (continuous infusion terlipressin) was granted FDA Fast Track status and FDA Orphan Drug designation for ascites due to all etiologies except cancer. BIV201 is being evaluated as a treatment option for patients suffering from life-threatening complications of liver cirrhosis and ascites due to hepatitis, nonalcoholic steatohepatitis, and alcoholism.

Knightscope Inc is a security technology and managed services company building the nation's first Autonomous Security Force (ASF), a unified force that integrates autonomous machines, software, real-time monitoring, and licensed security agents under a single managed service accountable for the security of the people, property, and places it protects. The company delivers the ASF as one integrated managed services offering that combines Autonomous Security Robots (ASRs), including the stationary K1 Hemisphere and the mobile K5; Emergency Communication Devices (ECDs); and Others. It generates revenue from subscription-based Machine-as-a-Service offerings, ECD product sales and related recurring service contracts, and Security Force agent and executive protection services.